Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron augmentation for negative symptoms of schizophrenia
IRCT201112125280N7Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ondansetron in schizophrenia, sponsored by Mashhad University of Medical Sciences. Started Mar 2011; status: completed.
02
Drugs
ondansetron
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT201112125280N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201112125280N7.